Trial intelligence / Profile preview

Desmopressin Melt pharmacokinetics and pharmacodynamics in adults with nocturia and nocturnal polyuria

2011-000527-33Phase 3Terminated

Sponsor
Ghent University Hospital
Start
Feb 2011
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of desmopressin in nocturia and nocturnal polyuria (NP), sponsored by Ghent University Hospital. Primary endpoints: Urine production, Urine concentrating capacity and 1 more. Started Feb 2011; status: terminated.

02

Drugs

desmopressin
03

Conditions

nocturianocturnal polyuria (NP)

Beyond the preview

Go deeper on 2011-000527-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-000527-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call